Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05371041 · ClinicalTrials.gov registry record · NA

Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression

A NA study of Tourette Syndrome, sponsored by University of Florida.

Active
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT05371041 is a NA study of Tourette Syndrome that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 8 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05371041, a NA study of Tourette Syndrome, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The investigators will implant and monitor 8 research subjects with a subcortical closed-loop system for detection and suppression of tics in subjects with medically refractory debilitating Tourette Syndrome. The project will use the FDA-approved "Medtronic Percept PC" device, which is an implantable neurostimulator capable of recording neural signals. The study will target the CM nucleus of the thalamus and the aGPi in each brain hemisphere from each subject and we will connect the two leads placed in each brain hemisphere to two Percept devices.

Conditions Studied

Interventions

  • DEVICE Medtronic Percept Neurostimulator

Study Locations (1)

Florida

  • Norman Fixel Institute for Neurological Diseases - University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2022-06-20
Est. Completion 2026-08-31
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05371041

The ClinicalTrials.gov registry entry for NCT05371041 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (91% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Percept Neurostimulator is the first listed.

NCT05371041 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05371041 about?

NCT05371041 is a clinical study titled "Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression". The investigators will implant and monitor 8 research subjects with a subcortical closed-loop system for detection and suppression of tics in subjects with medically refractory debilitating Tourette Syndrome. The project will use the FDA-approved "Medtronic Percept PC" device, which is an implantabl...

What is the current status of trial NCT05371041?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2022-06-20. Estimated completion is 2026-08-31.

What conditions does trial NCT05371041 study?

This clinical trial studies the following conditions: Tourette Syndrome.

What interventions are being tested in trial NCT05371041?

The interventions under investigation include: Medtronic Percept Neurostimulator (DEVICE).

Who is sponsoring clinical trial NCT05371041?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05371041 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.